Projects per year
Fingerprint
Dive into the research topics where Salma Jabbour is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
North American Star Consortium
Jabbour, S., BEDARD, P., SIU, L., Grant, S., OZA, A., SIU, L., Sullivan, D. & Grant, S.
4/7/14 → 2/28/23
Project: Research project
-
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
Mehnert, J., Jabbour, S., Dipaola, R., Liu, G., Liu, G. & Liu, G.
3/19/14 → 2/28/21
Project: Research project
-
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and Guidelines
Kumar, R., Tchelebi, L., Anker, C. J., Sharma, N., Bianchi, N. A., Dragovic, J., Goodman, K. A., Herman, J. M., Jiang, Y., Jones, W. E., Kennedy, T. J., Lee, P., Kundranda, M., Russo, S., Small, W., Suh, W. W., Yee, N. & Jabbour, S. K., Sep 1 2022, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 45, 9, p. 391-402 12 p.Research output: Contribution to journal › Article › peer-review
-
Analysis of Outcomes with Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer - Reply
Jabbour, S. K., Keller, S. M. & Reck, M., Jan 2022, In: JAMA Oncology. 8, 1, p. 168-169 2 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer
Malhotra, J., Ryan, B., Patel, M., Chan, N., Guo, Y., Aisner, J., Jabbour, S. K. & Pine, S., Jun 2022, In: Journal of Thoracic Disease. 14, 6, p. 1772-1783 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Combining natural and artificial intelligence for robust automatic anatomy segmentation: Application in neck and thorax auto-contouring
Udupa, J. K., Liu, T., Jin, C., Zhao, L., Odhner, D., Tong, Y., Agrawal, V., Pednekar, G., Nag, S., Kotia, T., Goodman, M., Wileyto, E. P., Mihailidis, D., Lukens, J. N., Berman, A. T., Stambaugh, J., Lim, T., Chowdary, R., Jalluri, D., Jabbour, S. K., & 10 others, Nov 2022, In: Medical Physics. 49, 11, p. 7118-7149 32 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
Schoenfeld, J. D., Giobbie-Hurder, A., Ranasinghe, S., Kao, K. Z., Lako, A., Tsuji, J., Liu, Y., Brennick, R. C., Gentzler, R. D., Lee, C., Hubbard, J., Arnold, S. M., Abbruzzese, J. L., Jabbour, S. K., Uboha, N. V., Stephans, K. L., Johnson, J. M., Park, H., Villaruz, L. C., Sharon, E., & 17 others, Feb 2022, In: The Lancet Oncology. 23, 2, p. 279-291 13 p.Research output: Contribution to journal › Article › peer-review
35 Scopus citations